# TEVIMBRA

NDC: 72579-121
Generic name: tislelizumab-jsgr
Labeler / Manufacturer: BeOne Medicines USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20240314

FDA application: BLA761232

## Active ingredients

- TISLELIZUMAB: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72579-121"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72579-121
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=08ef1e3e-496f-4b0b-94ee-fbba3cc1985a